VTGN

Adler Reid G.

Known title: CHIEF LEGAL OFFICERCIK: 0001924908

Adler Reid G.'s purchase track record

Adler Reid G. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
8/17/2022VTGN$51K-21.1%+5.3%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 2, 2026

VTGN linked to growing vasomotor symptoms market amid recent price dip. The vasomotor symptoms market is projected to expand through 2036 as adoption of hormonal and non‑hormonal therapies rises, a trend that aligns with VTGN’s focus on treatments for menopausal symptoms. At the same time, VTGN appeared on a recent list of falling stocks that traders are watching, indicating recent price weakness. These factors together provide context for the stock’s current market environment.

this person other insiders at VTGN

Transaction History

VTGN▲ Buy$7K
VTGN▲ Buy$13K
VTGN▲ Buy$14K
VTGN▲ Buy$287
VTGN▲ Buy$265
VTGN▲ Buy$51K

We use analytics to understand how market-wall is used. No personal data is sold.